001     295921
005     20241227115429.0
024 7 _ |a 10.1007/s00520-024-09068-z
|2 doi
024 7 _ |a pmid:39694910
|2 pmid
024 7 _ |a 0941-4355
|2 ISSN
024 7 _ |a 1433-7339
|2 ISSN
037 _ _ |a DKFZ-2024-02734
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Sweegers, Maike G
|b 0
245 _ _ |a Metastatic breast cancer patients' preferences for exercise programs: a latent class analysis using data from a survey in five European countries.
260 _ _ |a New York,NY
|c 2025
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1735296845_21519
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We aimed to identify metastatic breast cancer (MBC) patients' preferences for exercise programs and identify patients' characteristics associated with these preferences, to facilitate implementation of exercise programs for MBC patients.We used data from a multinational cross-sectional survey conducted among MBC patients. Patients reported their preferred exercise frequency, intensity, type, session duration, and supervision mode. We used latent class analysis to identify subgroups with similar preferences and descriptive statistics to compare demographic and clinical characteristics of patients within subgroups.Four distinct classes were identified based on data from 409 participants. Class 1 (47% of participants) is characterized by a preference for moderate exercise with supervision within the health care setting. Most participants in this class had bone metastases. Class 2 (30%) is characterized by a preference for vigorous exercise with supervision. This class included participants who were, on average, younger, and had a higher education level. Class 3 (13%) is characterized by a preference for active walking. These participants were less likely to have bone metastases or comorbidities. Class 4 (10%) is characterized by a preference for recreational walking and included participants who were, on average, older, and less likely to be employed.We identified four classes of patients with different preferences for exercise programs. Many patients with MBC express exercise preferences that meet the current guideline recommendations. Some patients with MBC may benefit from targeted education to align their preferences and behavior with the amount of exercise that is necessary to gain health benefits.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Exercise preferences
|2 Other
650 _ 7 |a Latent class analysis
|2 Other
650 _ 7 |a Metastatic breast cancer
|2 Other
650 _ 7 |a Patient perspectives
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Breast Neoplasms: pathology
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Patient Preference
|2 MeSH
650 _ 2 |a Europe
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Latent Class Analysis
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Surveys and Questionnaires
|2 MeSH
650 _ 2 |a Exercise Therapy: methods
|2 MeSH
650 _ 2 |a Bone Neoplasms: secondary
|2 MeSH
650 _ 2 |a Exercise: physiology
|2 MeSH
650 _ 2 |a Neoplasm Metastasis
|2 MeSH
650 _ 2 |a Age Factors
|2 MeSH
700 1 _ |a Depenbusch, Johanna
|0 P:(DE-He78)02b45d03ea9bc2c222c7aebf546803c5
|b 1
700 1 _ |a Aaronson, Neil K
|b 2
700 1 _ |a Hiensch, Anouk E
|b 3
700 1 _ |a Wengström, Yvonne
|b 4
700 1 _ |a Backman, Malin
|b 5
700 1 _ |a Gunasekara, Nadira
|b 6
700 1 _ |a Clauss, Dorothea
|b 7
700 1 _ |a Belloso, Jon
|b 8
700 1 _ |a Lachowicz, Milena
|b 9
700 1 _ |a May, Anne M
|b 10
700 1 _ |a Steindorf, Karen
|0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
|b 11
|u dkfz
700 1 _ |a Stuiver, Martijn M
|b 12
773 _ _ |a 10.1007/s00520-024-09068-z
|g Vol. 33, no. 1, p. 39
|0 PERI:(DE-600)1463166-0
|n 1
|p 39
|t Supportive care in cancer
|v 33
|y 2025
|x 0941-4355
909 C O |p VDB
|o oai:inrepo02.dkfz.de:295921
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)02b45d03ea9bc2c222c7aebf546803c5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SUPPORT CARE CANCER : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C110-20160331
|k C110
|l Bewegung, Präventionsforschung und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C110-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21